** Hera Med's Australia-listed shares rise as much as 4.8% to A$0.022, their highest level since Sept 12
** Israel-based maternity technology co signs letter of intent with Founda Health to enter into strategic partnership
** Says it will use Founda's platform to integrate its HeraCARE solution with electronic health records within the hospital systems and ensure better service to expectant mothers
** Stock had fallen 9.5% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。